Tư vấn lần đầu (trong vòng 30 phút)
$245 trở lên
Lần tư vấn đầu tiên dài (trong vòng 30 - 60 phút)
$345.00 trở lên
Tư vấn tiếp theo (trong vòng 30 phút)
$165.00 trở lên
Tư vấn theo dõi lâu dài (trong vòng 30-60 phút)
$245.00 trở lên
Tư vấn khẩn cấp (W/IN 30 phút)
$385.00 trở lên
Tư vấn khẩn cấp kéo dài (W/IN 30-60 phút)
$550.00 trở lên
Phí chuyên môn băng bó vết thương (không bao gồm vật tư tiêu hao)
$132.00 - 228.00 (tùy thuộc vào độ phức tạp)
Đánh giá siêu âm Duplex bổ sung tại phòng khám
$150.00 - $320.00 (tùy thuộc vào độ phức tạp)
Báo cáo y tế chuyên khoa
$200.00 - $ $330.00 (tùy thuộc vào độ phức tạp)
Vbeam Laser (giới hạn 30 lần/buổi)
$650 trở lên
Vbeam Laser (Gói 5 + 1)
$3,250 trở lên
Laser Gmax (theo vùng bị ảnh hưởng/buổi điều trị)
$650 trở lên
Gmax Laser (Gói 5 + 1)
$3,250 trở lên
Q-Switch Laser (mỗi vùng/phiên bị ảnh hưởng)
$650 trở lên
Q-Switch Laser (Gói 5 + 1)
$3,250 trở lên
Tư vấn bệnh nhân nội trú tại bệnh viện (Phường)
$380.00 trở lên
Tư vấn nội trú tại bệnh viện (ICU)
$550.00 trở lên
A&E trong giờ làm việc của Phòng khám
$380.00 trở lên
A&E sau giờ làm việc của Phòng khám nhưng trước 12 giờ đêm
$480.00 trở lên
A&E sau 12 giờ đêm
$550.00 trở lên
Cuối tuần A&E & PH
$550.00 trở lên
* Tất cả giá đều tính theo đơn vị tiền tệ Singapore, không bao gồm Thuế hàng hóa và dịch vụ, giá chính xác kể từ ngày 1 tháng 1 năm 2025 trở đi. Giá có thể thay đổi theo.
Transarterial Microembolisation (TAME) is a minimally invasive endovascular procedure used to manage chronic pain associated with osteoarthritis and selected musculoskeletal conditions. When applied to the knee, it is known as Genicular Artery Embolisation (GAE).
In Singapore, TAME and GAE may be considered for selected patients who continue to experience knee and musculoskeletal pain despite conservative treatment and are exploring alternatives to knee replacement surgery.
Transarterial Microembolisation (TAME) is an image-guided endovascular technique designed to address the vascular component of chronic musculoskeletal pain.
Rather than treating the joint surface or cartilage directly, TAME focuses on abnormal small blood vessels that develop in chronically inflamed tissues. In conditions such as osteoarthritis, these abnormal microvessels are associated with ongoing inflammation and pain signalling.
TAME involves the selective delivery of microscopic embolic particles into these vessels, reducing blood flow to inflamed tissue while preserving normal circulation to surrounding structures.
The procedure is performed through a small arterial access under imaging guidance and does not involve open surgery. As it targets inflammation rather than structural joint damage, TAME is used as a pain management strategy rather than a curative treatment for osteoarthritis.
When Transarterial Microembolisation is applied to the knee, the procedure is known as Genicular Artery Embolisation (GAE).
Knee osteoarthritis is commonly associated with chronic inflammation of the joint lining and surrounding soft tissues. This inflammation is often accompanied by the formation of abnormal genicular blood vessels, which contribute to pain and reduced function.
GAE targets these abnormal vessels supplying inflamed areas around the knee joint. Using angiographic imaging, the genicular arteries involved in the inflammatory process are carefully identified and selectively embolised. This helps reduce inflammation and pain while maintaining the main blood supply to the leg and knee.
GAE is currently the most established and studied application of TAME, with growing clinical evidence supporting its role in managing knee osteoarthritis pain in selected patients.
TAME and GAE reduce pain by targeting the underlying inflammatory and vascular processes, rather than the joint surfaces themselves.
In osteoarthritis and related conditions:
By selectively embolising these abnormal vessels, TAME and GAE may:
Because the treatment is highly targeted, normal blood supply to the limb is preserved. Pain improvement may occur gradually over several weeks as inflammation settles.
Transarterial Microembolisation (TAME) and Genicular Artery Embolisation (GAE) may be considered for selected patients with chronic pain related to osteoarthritis, most commonly involving the knee.
These procedures are typically considered when symptoms persist despite appropriate conservative treatment.
TAME may be suitable if you have ongoing knee pain that affects daily activities and you are exploring a minimally invasive option to manage symptoms.
This approach may be considered if you:
A consultation is important to determine whether an endovascular approach is appropriate and to set realistic expectations.
For advanced osteoarthritis, knee replacement surgery remains an established treatment that can improve pain and function for many patients.
However, some patients may not wish to proceed with joint replacement early and others may not be suitable candidates for major surgery.
In selected cases, TAME and GAE may be “alternatives” or interim treatments to knee replacement surgery, particularly when the goal is pain reduction and improved day-to-day function rather than correction of structural joint damage.
These procedures do not reverse cartilage loss and they are not intended to replace knee replacement surgery in severe, end-stage osteoarthritis.
TAME and GAE are commonly considered when:
TAME is a minimally invasive, image-guided procedure and is usually performed under local anaesthesia, without the need for open surgery.
A small arterial access is used, commonly at the groin or wrist, through which a catheter is guided under imaging to the target blood vessels. The procedure typically takes around one to two hours.
Most patients can mobilise shortly afterwards, and many cases are suitable for day surgery, allowing patients to return home the same day.
In most cases, patients can expect:
Aftercare and activity advice will be tailored to the individual.
Clinical studies suggest that TAME is generally well-tolerated when performed in appropriately selected patients. Many individuals experience improvements in pain and daily function, although the degree of improvement can vary.
It is important to understand that these procedures are not curative and do not halt the progression of osteoarthritis. Pain improvement may be gradual and can take several weeks as inflammation settles.
Possible limitations and side effects include:
Expected benefits, risks and alternative treatment options will be discussed before any procedure is recommended.
Transarterial Microembolisation is usually performed under local anaesthesia. Most patients experience minimal discomfort during the procedure. Some mild soreness or aching may occur afterwards, but this is typically temporary.
Pain improvement is often gradual rather than immediate. Many patients notice improvement over several weeks as inflammation settles. The degree and timing of relief can vary between individuals.
The duration of symptom relief varies between patients. Some experience sustained improvement, while others may notice symptoms returning over time. This can depend on disease severity, activity level and progression of osteoarthritis.
Yes. In selected cases, Transarterial Microembolisation may be repeated if symptoms recur and reassessment shows that repeat treatment is appropriate. This is decided on an individual basis following clinical review and imaging.
Transarterial Microembolisation does not preclude future surgery, including knee replacement if it becomes necessary later. When the procedure is performed for knee osteoarthritis, this is referred to as Genicular Artery Embolisation.
Transarterial Microembolisation is primarily considered for osteoarthritis-related pain and selected musculoskeletal conditions where inflammation plays a significant role. It is not suitable for all causes of joint pain, and assessment is required.
The procedure targets abnormal microvessels associated with inflammation while preserving normal blood supply to the limb. Serious long-term complications are uncommon when the procedure is performed in appropriately selected patients.
Suitability is determined through a consultation with a vascular specialist, including clinical assessment and imaging. This helps ensure the treatment is appropriate and expectations are realistic.
MBChB, FRCS(Glas), FRCS(Anh), FRCS(Gen), FAM
MA Honours, MB BChir (Giải thưởng phẫu thuật), MRCS Glas, MD (Cambridge), FRCS (Gen); FAMS; CWSP
MDCM (Đại học McGill); Hội đồng phẫu thuật Hoa Kỳ (Tổng quát, Mạch máu); FAMS; RPVI
